Disclosures

Royalties received from DePuy, A Johnson & Johnson Company, OrthoDevelopment
Speaker for Convatec, DePuy, A Johnson & Johnson Company
Paid Consultant for DePuy, A Johnson & Johnson Company, TJO
Royalties or support received from Elsivier
Editorial or Governing board of Journal of Arthroplasty
Board of Directors member for AAOS, American Association of Hip and Knee Surgeons, American Joint Regitry Steering Committee, Hip Society, Knee Society
All relevant financial disclosures have been mitigated.
Disclosures complete: Oct 21, 2023